TY  - JOUR
AU  - Shen, Jing
AU  - Najafi, Sara
AU  - Stäble, Sina
AU  - Fabian, Johannes
AU  - Koeneke, Emily
AU  - Kolbinger, Fiona
AU  - Wrobel, Jagoda
AU  - Meder, Benjamin
AU  - Distel, Martin
AU  - Heimburg, Tino
AU  - Sippl, Wolfgang
AU  - Jung, Manfred
AU  - Peterziel, Heike
AU  - Kranz, Dominique
AU  - Boutros, Michael
AU  - Westermann, Frank
AU  - Witt, Olaf
AU  - Oehme, Ina
TI  - A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment.
JO  - Cell death and differentiation
VL  - 25
IS  - 12
SN  - 1476-5403
CY  - London
PB  - Macmillan
M1  - DKFZ-2018-02364
SP  - 2053 - 2070
PY  - 2018
AB  - The prognosis of advanced stage neuroblastoma patients remains poor and, despite intensive therapy, the 5-year survival rate remains less than 50
LB  - PUB:(DE-HGF)16
C6  - pmid:29515255
C2  - pmc:PMC6261943
DO  - DOI:10.1038/s41418-018-0080-0
UR  - https://inrepo02.dkfz.de/record/142134
ER  -